Skip to content
Recall Observatory FDA recall evidence

Drug product

BEVACIZUMAB 1.25 mg/0.05 mL 31G MJ syringe Intravitreal Injection. This biologic product was repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901 Lot:190212AB BUD:5/13/2019, Repackaged on 2/12/2019

D-1271-2019

April 19, 2019

Class II

Product summary

Firm
Pacifico National, Inc. dba AmEx Pharmacy
Event
Event 82676
Status
Terminated
Classification
Class II
Quantity
249 syringes
Official record key
drug-enforcement:D-1271-2019

Official wording

Reason: Defective Delivery System: difficult to express

Code information: Lot: 190212AB BUD: 5/13/2019

Distribution pattern: Nationwide in the US

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Defective Delivery System: difficult to express